Published in Antibiot Med Biotekhnol on March 01, 1986
[Bacillus subtilis mutants resistant to roseoflavin]. Genetika (1982) 0.81
[Long-term results of HBV and HCV infection in patients with blood system diseases]. Ter Arkh (2011) 0.81
[Absence of phage production in bacteria lysogenized by a non-inducible phage during repressor inactivation]. Dokl Akad Nauk SSSR (1969) 0.80
[Transformation of Streptomyces bambergiensis S712 by plasmid DNA]. Antibiot Khimioter (1988) 0.78
[Effect of plasmid pIJ350 on genetic stability of antibiotic production by Streptomyces bambergiensis]. Antibiot Khimioter (1989) 0.76
[The discovery of giant linear plasmids in strains of Streptomyces bambergiensis]. Dokl Akad Nauk SSSR (1990) 0.76
The use of mutagenic factors in the selection of the riboflavin producer Eremothecium ashbyii. Sov Genet (1974) 0.75
[Transketolase mutation in riboflavin-synthesizing strains of Bacillus subtilis]. Mol Gen Mikrobiol Virusol (2000) 0.75
Mutants of Eremothecium ashbyii resistant to 8-azaguanine. Communication I. Isolation of mutants and study of the level of riboflavin biosynthesis. Sov Genet (1974) 0.75
[Transformation of Bacillus licheniformis by plasmid DNA]. Genetika (1983) 0.75
[Physico-chemical properties of the RNA of Sendai virus. III. Interaction with proflavin]. Mol Biol (Mosk) (1978) 0.75
[Effect of auxotrophic mutations on the bacitracin production level in Bacillus licheniformis]. Antibiotiki (1981) 0.75
Use of fast neutrons in selection of erythromycin producer Actinomyces erythreus. Fed Proc Transl Suppl (1965) 0.75
[Fusion of Bacillus subtilis and Bacillus licheniformis protoplasts. Interspecies recombination resulting from protoplast fusion]. Antibiot Med Biotekhnol (1985) 0.75
[Virulent and temperate phages of Bacillus licheniformis, the producer of bacitracin antibiotic]. Mikrobiologiia (1978) 0.75
[Cytomorphological and cultural characteristics of tylosin-producing strains with different antibiotic activity]. Antibiot Khimioter (1991) 0.75
Effective properties of suspensions/emulsions, porous and composite materials. Adv Colloid Interface Sci (2007) 0.75
[Preparation of an active strain of Bacillus licheniformis--producer of thermostable alpha-amylase]. Prikl Biokhim Mikrobiol (2002) 0.75
[Induction of bacterial genes during infection by phages]. Dokl Akad Nauk SSSR (1968) 0.75
[Restriction of the multiplication of rII mutants of T-even phages in bacteria lysogenized by phage 299]. Mikrobiologiia (1970) 0.75
[Circular dichroism spectra study on the ribonucleoprotein structure of influenza virus]. Mol Biol (Mosk) (1982) 0.75
[Sedimentation and electron microscopic characteristics of RNA isolated from a highly concentrated suspension of Sendai virus]. Vopr Virusol (1981) 0.75
[Proteolytic cleavage of influenza virus matrix protein and nucleoprotein in an in vitro system]. Vopr Virusol (1984) 0.75
[New approaches to the chemotherapy of HIV infection]. Zh Mikrobiol Epidemiol Immunobiol (1999) 0.75
[Production of isolated colonies in Blakeslea trispora]. Mikrobiologiia (1977) 0.75
[Effect of bacitracin and other drugs on the synthesis of the antibiotic itself (bacitracin) by a Bacillus licheniformis culture]. Antibiotiki (1981) 0.75
[Analysis of the patient contingent at a specialized pediatric clinic]. Zh Nevropatol Psikhiatr Im S S Korsakova (1988) 0.75
[Use of the protoplast fusion method in the selection of Streptomyces griseus--the producer of the streptothricin antibiotic grisin]. Antibiotiki (1983) 0.75
[Riboflavin and lumiflavin analogs and alloxazine derivatives. I. Effect on riboflavin synthesis by and growth of Bacillus subtilis]. Genetika (1975) 0.75
[Selective suppression of cytokinesis as a result of lysogenization]. Mikrobiologiia (1971) 0.75
[Biosynthesis of the antibiotic, grizin, by prototrophic revertants of Streptomyces griseus biochemical mutants]. Antibiotiki (1980) 0.75
[Eremothecium ashbyii mutants resistant to 8-azaguanine. II. Mutants with different degrees of resistance to 8-azaguanine]. Genetika (1975) 0.75
[Serotypical profile of HIV infection in Moscow]. Vopr Virusol (1999) 0.75
[Analysis of the immunologic heterogeneity of HIV-1. II. Effect of amino acid residues, flanking the C-terminus of the central tetrapeptide loop V3 of gp120]. Mol Biol (Mosk) (1998) 0.75
[Molecular genetic study of the strain Streptomyces virginiae-- the producer of virginiamycin]. Genetika (1996) 0.75
[Circular dichroism study of the ribonucleoprotein structure of Sendai virus isolated from infected chick embryo cells]. Vopr Virusol (1982) 0.75
[Biological properties of primary HIV-1 isolates with varying serotype]. Vopr Virusol (1999) 0.75
[Characteristics of Actinomyces griseus actinophages and the production of phage-resistant mutants of the producer of grisin]. Antibiotiki (1975) 0.75
[Isolation and characteristics of a plasmid from the thermotolerant strain of Bacillus licheniformis]. Mol Gen Mikrobiol Virusol (1987) 0.75
[Laboratory diagnosis of herpesvirus infections in patients with acute leukemias]. Vopr Virusol (2009) 0.75
[Effect of the isolation method and staining procedure on the morphology of the virion ribonucleoprotein of Sendai virus]. Vopr Virusol (1981) 0.75
[A functional model of the central epitope of the V3 loop of HIV-1 gp120 when complexed with antibodies]. Mol Biol (Mosk) (1999) 0.75
[Optimum conditions for germinating spores of the fungus Eremothecium ashbyii producing riboflavin]. Prikl Biokhim Mikrobiol (1974) 0.75
[Biochemical mutants of Actinomyces griseus, a producer of the antibiotic grisin. The isolation of the mutants and a study of the level of grisin antibiotic synthesis]. Antibiotiki (1979) 0.75
[Determination of antibodies to the AIDS virus and the viral antigen by an immunoenzyme method using peroxidase and beta-lactamase]. Vopr Virusol (1988) 0.75
[Further improvement of the methods for the arrest of nasal bleeding]. Vestn Otorinolaringol (2010) 0.75
[Changes in the level of bacitracin synthesis in autolysin-resistant strains of Bacillus licheniformis]. Antibiotiki (1981) 0.75
[Eremothecium ashbyii mutants resistant to 2,6-diaminopurine]. Genetika (1975) 0.75
[Reversible dissociation of influenza virus ribonucleoprotein]. Vopr Virusol (1984) 0.75
[Effect of amino acid substitutions in the gp120 V3-loop sequence on serological cross-reactivity between various HIV-1 subtypes]. Mol Biol (Mosk) (1997) 0.75
[Identification of bacteriophages and study of the properties of phage-resistant mutants of Bacillus thuringiensis var. galleriae]. Nauchnye Doki Vyss Shkoly Biol Nauki (1975) 0.75
[Action of grisin on the variability of an Acinomyces griseus culture and the use of the same antibiotic as a selection agent in the selection of active variants]. Antibiotiki (1979) 0.75
[Eremothecium ashbyii mutants resistant to 8-azaguanine. III. Nucleotide pyrophosphorylase activity of mutants with a varying degree of 8-azaguanine resistance]. Genetika (1982) 0.75
[Identification of immunoreactive epitopes in proteins coded by gag, env, and pol genes of the type I human T-lymphotropic virus (HTLV-I) using synthetic peptides]. Bioorg Khim (1995) 0.75
[Conditions for Bacillus licheniformis protoplast formation and regeneration to the bacillary form]. Mikrobiologiia (1981) 0.75
[Induced and spontaneous mutagenesis in phage T4 in Escherichia coli strains with mutant RNA polymerase]. Genetika (1975) 0.75
[Analysis of the immunologic heterogeneity of HIV-1: I. "Arginine-glutamine trigger" in the fourth position of the central tetrapeptide of the V3 loop of gp120]. Mol Biol (Mosk) (1998) 0.75
[Relation of bacitracin synthesis and manganese content in Bacillus licheniformis: antibiotic production in colonies forming on media with high levels of Mn2+]. Antibiot Khimioter (1989) 0.75
[Reversion induction in phage T4 mutants in Escherichia coli strains with defective RNA polymerase]. Genetika (1975) 0.75
[Detection of the human immunodeficiency virus in a lymphocyte culture from a patient from Central Africa with acquired immunodeficiency syndrome and Kaposi's sarcoma]. Vopr Virusol (1988) 0.75
[The molecular epidemiological characteristics of the HIV-1 variants circulating among injection drug addicts on the territory of the CIS Nations]. Zh Mikrobiol Epidemiol Immunobiol (1999) 0.75
[Serological properties of HIV-1 isolates from the focus of an epidemic in the Gomel region of the Belarus Republic (1996)]. Vopr Virusol (1999) 0.75
[Morphological and structural studies of Sendai virus ribonucleoprotein]. Vopr Virusol (1982) 0.75
[Effect of mutant RNA polymerase on spontaneous mutagenesis in bacteriophage T4]. Genetika (1975) 0.75
[Increase in the serotypical heterogeneity in HIV-1 in Svetlogorsk focus 1 year after the start of an epidemic]. Vopr Virusol (1999) 0.75
[Nitrogen assimilation enzymes in Bacillus subtilis mutants with hyperproduction of riboflavin]. Mol Gen Mikrobiol Virusol (2005) 0.75
[Enhanced immunogenicity of influenza virus surface proteins when incorporated into liposomes]. Vopr Virusol (1986) 0.75
[Effect of the matrix protein of the influenza virus on oxidative phosphorylation in preparations of isolated liver mitochondria from white mice]. Vopr Virusol (1988) 0.75
[Serotypical stratification of HIV-1 in populations of intravenous drug users in the south/southwestern Ukraine]. Vopr Virusol (1998) 0.75
[Physico-chemical properties of Sendai virus RNA. I. Fractionation on hydroxylapatite]. Mol Biol (Mosk) (1979) 0.75